News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Second Biotech Accelerator, Indie Bio, Launches In SF And Ireland



10/9/2014 6:34:15 AM

Second Biotech Accelerator, Indie Bio, Launches In SF And Ireland

October 9, 2014

By Jessica Wilson, BioSpace.com Breaking News Staff

SOS Ventures, the Cork, Ireland-based venture capital firm, is launching a biotech accelerator in November called IndieBio, with locations in both San Francisco, Calif. and in Cork. The venture firm already runs accelerator programs for software and hardware startups. According to an article today in Xconomy, IndieBio is primarily interested in the biotech sectors of “bioinformatics, automated lab technology, and the intensive form of genetic engineering known as synthetic biology.”

“These accelerators are a third way for people to build their own dreams and secure their own futures,” IndieBio co-founder Arvind Gupta and partner at SOS Ventures was quoted as saying. His vision is to provide the entrepreneurs accepted into IndieBio’s program with a “financial and technology ecosystem” located outside big companies and universities, where they will have more freedom.

IndieBio is drawing comparisons to Y Combinator, the Mountain View, CA-based accelerator that welcomed its first biotech class this summer. Gupta looks at Y Combinator as a partner in building a supportive environment for biotech entrepreneurs rather than as a competitor. “None of us are competing,” he was quoted as saying. “If we can’t build that ecosystem, whatever businesses we help build will fail.”
  Related Jobs  
  Research Associate - Regeneron Pharma
  Scientist / Assoc. Manager - Regeneron Pharma
  Research Associate - Regeneron Pharma
  Postdoctoral Fellow - Pfizer
  Research Associate - Bristol-Myers Squibb
  Research Scientist - Gilead Sciences
  View More Jobs


Gupta joined SOS Ventures in 2013 with the goal to set up a biotech accelerator. His interest lies specifically in synthetic biology; however, IndieBio will welcome a wide array of biotech startups.

Gupta’s fellow SOS Ventures partner Bill Liao ran a six-month biotech accelerator in Cork earlier this year, the success of which inspired him to co-create IndieBio with Gupta. An example of the type of startups the two are looking for is a Cork graduate called Muufri (pronounced moo-free), which is a company that uses bio-engineered microbes to produce an “animal-free” milk substitute.

IndieBio will soon move to a large space in downtown San Francisco, where the startups will set up shop—in both offices and labs—during their sessions. SOS will provide $35,000 to each startup for 8 percent equity. Gupta explained that this is different than Y Combinator, which provides $125,000 to each start-up, but does not set each one up in an office or a lab. Other benefits for startups in IndieBio will include access to mentors and contacts that could lead to additional investors.

IndieBio will run two sessions in San Francisco, one beginning in January and the other in May. The first session’s application deadline is November 1, for ten available spots.


Read at BioSpace.com


comments powered by Disqus
Indie Bio
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES